Interest in turmeric as a tonic and regenerative agent for brain conditions is growing rapidly. Given the increased prevalence of neurodegenerative conditions such as Alzheimer’s disease, as well as an alarming uptick in brain cancer and the cognitively impairing metabolic dysregulations associated with type 2 diabetes.
Turmeric and its primary polyphenol curcumin hold great promise as an alternative to pharmaceuticals, none of which have been shown to address nor resolve the root causes of disease.
A recent study published in the Asia Pacific Journal of Clinical Nutrition titled, “Turmeric improves post-prandial working memory in pre-diabetes independent of insulin“, reveals the unique therapeutic profile of this ancient Indian spice in preventing cognitive impairment linked to pre-diabetes and dementia.
The study enrolled 48 60-year olds with newly recognized yet untreated pre-diabetes. They were randomized to receive either a placebo, turmeric (1,000 mg), cinnamon (2,000 mg) or both (1,000 mg & 2,000 mg respectively), ingested at a white bread (119 g) breakfast.
The researchers observed the participants’ metabolic responses over a 6 hour period for the following parameters:
· Pre- and post-working memory (WM),
· Glycemic and insulin responses
· Biomarkers of Alzheimer’s disease (AD)(measured at 0, 2, 4 and 6 hours):